Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
Gilead Sciences Partners With White House for Early Cancer Detection Program "Biden Cancer Moonshot"
NORTHAMPTON, MA / ACCESSWIRE / May 28, 2024 / Gilead Sciences:
馬薩諸塞州北安普敦/ACCESSWIRE/2024 年 5 月 28 日/吉利德科學：
In an effort to advance access to cancer prevention and early detection among U.S. workers, the Biden Cancer Moonshot recently announced a series of actions that organizations are taking to improve access and use of cancer screenings. We're proud to be included on the list for our commitment to help increase screening rates among employees through personalized outreach.
爲了促進美國工人獲得癌症預防和早期發現的機會，拜登癌症月球組織最近宣佈了一系列行動，各組織正在採取這些行動，以改善癌症篩查的可及性和使用率。我們很榮幸能被列入名單，以表彰我們致力於通過個性化宣傳幫助提高員工的篩選率。
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.
Gilead Sciences, Inc. 是一家以研究爲基礎的生物製藥公司，在醫療需求未得到滿足的領域發現、開發和商業化創新藥物。該公司致力於改變和簡化對世界各地患有危及生命的疾病患者的護理。吉利德在全球超過35個國家開展業務，總部位於加利福尼亞州福斯特城。
Originally published by Gilead Sciences
最初由吉利德科學出版
View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.
在 3blmedia.com 上查看吉利德科學提供的更多多媒體和更多 ESG 故事。
Contact Info:
聯繫信息：
Spokesperson: Gilead Sciences
發言人：吉利德科學
SOURCE: Gilead Sciences
來源：吉利德科學